Annual Review 2012 - Luxottica
Annual Review 2012 - Luxottica
Annual Review 2012 - Luxottica
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
170 |<br />
ANNUAL REPORT <strong>2012</strong><br />
as such, the holders of these options became entitled to exercise such options beginning<br />
on that date until their termination in 2014. During <strong>2012</strong>, 3.9 million options (0.7 million in<br />
2011) from this grant were exercised. As of December 31, <strong>2012</strong>, 3.4 million options were<br />
outstanding.<br />
A summary of related party transactions as of December 31, <strong>2012</strong> and 2011, is provided<br />
below. In 2011, the Group completed the acquisition of Multiopticas, which is no longer<br />
considered a related party as of December 31, 2011. Please refer to note 4 “Business<br />
Combinations” for further details. The table below reports the revenues and costs related<br />
to the transactions with Multiopticas that occurred until the completion of the acquisition.<br />
As of December 31, <strong>2012</strong><br />
Related parties (thousands of Euro)<br />
Consolidated<br />
Statement of Income<br />
Consolidated<br />
Statement of Financial Position<br />
Revenues Costs Assets Liabilities<br />
Brooks Brothers Group, Inc. - 802 13 40<br />
Eyebiz Laboratories Pty Limited 1,194 44,862 7,898 9,086<br />
Others 650 764 447 72<br />
Total 1,844 46,428 8,358 9,198<br />
As of December 31, 2011<br />
Related parties (thousands of Euro)<br />
Consolidated<br />
Statement of Income<br />
Consolidated<br />
Statement of Financial Position<br />
Revenues Costs Assets Liabilities<br />
Brooks Brothers Group, Inc. - 984 - 155<br />
Multiopticas Group 4,743 25 1,600 2,465<br />
Eyebiz Laboratories Pty Limited 970 44,584 8,553 17,793<br />
Others 581 871 727 159<br />
Total 6,294 46,464 10,880 20,572<br />
Total remuneration due to key managers amounted to approximately Euro 43.2 million<br />
and Euro 48.9 million in <strong>2012</strong> and 2011, respectively.<br />
30. EARNINGS<br />
PER SHARE<br />
Basic and diluted earnings per share were calculated as the ratio of net income attributable<br />
to the stockholders of the Company for <strong>2012</strong> and 2011 amounting to Euro 541,700<br />
thousands and Euro 452,343 thousand, respectively, to the number of outstanding shares<br />
- basic and dilutive of the Company.<br />
Basic earnings per share in <strong>2012</strong> were equal to Euro 1.17, compared to Euro 0.98 in 2011,<br />
respectively. Diluted earnings per share in <strong>2012</strong> were equal to Euro 1.15 compared to<br />
Euro 0.98 in 2011, respectively.